Whilst low-rely MBL not often progresses to CLL, superior-depend MBL progresses to CLL requiring therapy at a fee of one% to two% per annum. Higher-count MBL is distinguished from Rai 0 CLL based upon whether the B-mobile count is over or under 5 × 109/L. Despite the fact that people today wit